UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recording and classifying MET receptor mutations in cancers

eLife, 2024-04, Vol.13

2024

Volltextzugriff (PDF)

Thirty years of research on met receptor to move a biomarker from bench to bedside

Cancer research (Chicago, Ill.), 2014-12, Vol.74 (23), p.6737-6744

2014

Volltextzugriff (PDF)

Alterations in the PI3K Pathway Drive Resistance to MET Inhibitors in NSCLC Harboring MET Exon 14 Skipping Mutations

Journal of thoracic oncology, 2020-05, Vol.15 (5), p.741-751

2020

Volltextzugriff (PDF)

The multiple paths towards MET receptor addiction in cancer

Oncogene, 2018-06, Vol.37 (24), p.3200-3215

2018

Volltextzugriff (PDF)

Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase

BMB Reports, 2019, 52(4), , pp.239-249

2019

Volltextzugriff (PDF)

ETV4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesis

Breast cancer research : BCR, 2018-07, Vol.20 (1), p.73-73, Article 73

2018

Volltextzugriff (PDF)

2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations

Nature communications, 2020-03, Vol.11 (1), p.1509-12, Article 1509

2020

Volltextzugriff (PDF)

Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients

Journal of thoracic oncology, 2018-12, Vol.13 (12), p.1873-1883

2018

Volltextzugriff (PDF)

Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase

BMB reports, 2019-04, Vol.52 (4), p.239-249

2019

Volltextzugriff (PDF)

Tensin-4-dependent MET stabilization is essential for survival and proliferation in carcinoma cells

Developmental cell, 2014-05, Vol.29 (4), p.421-436

2014

Volltextzugriff (PDF)

The ganglioside GD2 induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the GD3 synthase

Glycobiology (Oxford), 2012-06, Vol.22 (6), p.806-816

2012

Volltextzugriff (PDF)

Plasmodium pseudo-Tyrosine Kinase-like binds PP1 and SERA5 and is exported to host erythrocytes

Scientific reports, 2019-05, Vol.9 (1), p.8120, Article 8120

2019

Volltextzugriff (PDF)

Control of cell death/survival balance by the MET dependence receptor

eLife, 2020-02, Vol.9

2020

Volltextzugriff (PDF)

Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis

Molecular biology of the cell, 2009-05, Vol.20 (9), p.2495-2507

2009

Volltextzugriff (PDF)

GD₃ synthase expression enhances proliferation and tumor growth of MDA-MB-231 breast cancer cells through c-Met activation

Molecular cancer research, 2010-11, Vol.8 (11), p.1526-1535

2010

Volltextzugriff (PDF)

PTC readthrough in human cells occurs in novel cytoplasmic foci and requires UPF proteins

Journal of cell science, 2017-01

2017

Volltextzugriff (PDF)

Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonist

Chemical science (Cambridge), 2015-01, Vol.6 (3), p.2110-2121

2015

Volltextzugriff (PDF)

Loss of a negative feedback loop involving pea3 and cyclin d2 is required for pea3-induced migration in transformed mammary epithelial cells

Molecular cancer research, 2013-11, Vol.11 (11), p.1412-1424

2013

Volltextzugriff (PDF)

Proapoptotic Function of the MET Tyrosine Kinase Receptor through Caspase Cleavage

Molecular and Cellular Biology, 2004-12, Vol.24 (23), p.10328-10339

2004

Volltextzugriff (PDF)

Conservation of Epidermal Growth Factor Receptor Function in the Human Parasitic Helminth Schistosoma mansoni

The Journal of biological chemistry, 2004-09, Vol.279 (36), p.37407-37414

2004

Volltextzugriff (PDF)

Association of Fyn and Lyn with the Proline-rich Domain of Glycoprotein VI Regulates Intracellular Signaling

The Journal of biological chemistry, 2002-06, Vol.277 (24), p.21561-21566

2002

Volltextzugriff (PDF)

Orai3 calcium channel and resistance to chemotherapy in breast cancer cells: the p53 connection

Cell death and differentiation, 2018-03, Vol.25 (4), p.693-707

2018

Volltextzugriff (PDF)

Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers

JNCI : Journal of the National Cancer Institute, 2017-05, Vol.109 (5)

2017

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(84)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Life Sciences & Biomedicine
(58)
Humans
(49)
Animals
(40)
Life Sciences
(39)
Cell Biology
(26)
Biochemistry & Molecular Biology
(23)
Oncology
(20)
Mice
(18)
Proto-Oncogene Proteins C-Met - Metabolism
(18)
Mutation
(16)
Phosphorylation
(16)
Proto-Oncogene Proteins C-Met - Genetics
(16)
Met
(14)
Receptor Tyrosine Kinase
(13)
Cancer
(12)
Cell Line
(12)
Ligands
(12)
Amino Acid Sequence
(11)
Apoptosis
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recording and classifying MET receptor mutations in cancers

Thirty years of research on met receptor to move a biomarker from bench to bedside

Alterations in the PI3K Pathway Drive Resistance to MET Inhibitors in NSCLC Harboring MET Exon 14 Skipping Mutations

The multiple paths towards MET receptor addiction in cancer

Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase

ETV4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesis

2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations

Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients

Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase

Tensin-4-dependent MET stabilization is essential for survival and proliferation in carcinoma cells

The ganglioside GD2 induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the GD3 synthase

MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependent oncogenic driver in vitro and in humanised HGF knock-in mice

Plasmodium pseudo-Tyrosine Kinase-like binds PP1 and SERA5 and is exported to host erythrocytes

Control of cell death/survival balance by the MET dependence receptor

Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis

GD₃ synthase expression enhances proliferation and tumor growth of MDA-MB-231 breast cancer cells through c-Met activation

PTC readthrough in human cells occurs in novel cytoplasmic foci and requires UPF proteins

Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonist

Loss of a negative feedback loop involving pea3 and cyclin d2 is required for pea3-induced migration in transformed mammary epithelial cells

Proapoptotic Function of the MET Tyrosine Kinase Receptor through Caspase Cleavage

ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease

Conservation of Epidermal Growth Factor Receptor Function in the Human Parasitic Helminth Schistosoma mansoni

Association of Fyn and Lyn with the Proline-rich Domain of Glycoprotein VI Regulates Intracellular Signaling

Orai3 calcium channel and resistance to chemotherapy in breast cancer cells: the p53 connection

Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers

Suchergebnisse filtern